Throw the joint, roll the wheels!
Oral administration of cannabinoids has a more long-term analgesic effect than that which occurs when smoking marijuana.
24.04.2013Oral administration of cannabinoids has a more long-term analgesic effect than that which occurs when smoking marijuana.
24.04.2013Researchers have synthesized a compound whose oral administration significantly slows down the progression of Parkinson's disease, and possibly other neurodegenerative diseases caused by the formation of toxic protein aggregates in brain tissue.
24.04.2013Suppressing the formation of new blood vessels, the drug used to treat malignant tumors is effective in combating obesity.
24.04.2013An unusual method of cancer treatment: Listeria bacteria selectively infect cancer cells, acting as couriers for the delivery of radioisotopes, the radiation of which destroys tumor metastases.
23.04.2013Experiments on animal models have demonstrated the ability of new monoclonal antibodies to suppress the growth of triple-negative breast cancer and angiosarcoma by inhibiting angiogenesis.
23.04.2013In six cells of the "Homunculus", cells of organs (intestines, liver, lungs, heart, brain, skin) are cultivated, washed by the culture medium. In a closed system, conditions have been created that simulate the "life" of one hundred thousandth of a person.
22.04.2013Even moderate drinking increases the risk of breast cancer. On the other hand, moderate alcohol consumption increases the survival rate of patients after diagnosis. But it is necessary to start in advance, after – it is useless.
17.04.2013A new broad–spectrum antibiotic, active against "super-microbes" - microorganisms resistant to the action of other antibacterial agents, and not addictive to bacteria, has been successfully tested on animals.
17.04.2013Contrary to popular belief, type I interferons do not always help in the fight against viruses. In cases of pathogens prone to chronization, they contribute to the formation of persistent infections.
16.04.2013A molecule with the classification number AGI-6780 has been named as a promising candidate for the role of a possible targeted (that is, directed against well-marked molecular targets) anticancer drug.
15.04.2013The results of a phase I clinical trial demonstrated the safety and efficacy of an experimental drug based on artificial antibodies for the treatment of several types of cancer.
12.04.2013The results of the first phase I clinical trial of the drug, which is based on the phenomenon of RNA interference, indicate the safety and potential effectiveness of drugs of this class.
12.04.2013According to the results of the phase I clinical trial, 75% of patients with the last stages of recurrent ovarian cancer responded to the new two-stage immunotherapy. At the same time, one of them went into full remission.
12.04.2013Observing the joint evolution of HIV and antibodies directed against it allowed scientists to make valuable observations that give hope for the development of a long-awaited effective vaccine against this disease.
09.04.2013Vaccines based on "empty" viruses – synthetic shells without genetic material – are safer and cheaper to produce than vaccines made from weakened or killed viruses, and can be stored outside the refrigerator for longer.
05.04.2013Scientists from several US research centers have developed nanoparticles capable of encapsulating and releasing a peptide drug that stimulates the completion stage of the inflammatory process.
03.04.2013T-cell therapy, which consists in injecting the patient with his own T-lymphocytes reprogrammed to destroy malignant blood cells, allowed 2 children and 4 adults with severe forms of leukemia to go into remission.
01.04.2013A solution of modified lipopolysaccharide of the cell wall of the salmonella bacterium reduces the number and area of amyloid plaques in the brain of transgenic mice and improves their ability to remember.
29.03.2013Initially, the drug Veti-Gel was developed under the working name Medi-Gel – as a therapeutic gel in the Mass Effect video game series. Now the creation of such a gel can become a reality – its prototype was developed by a student of the University of New York.
26.03.2013An antitumor drug based on an oncolytic virus demonstrated good results in a phase III clinical trial involving patients with advanced stages of melanoma.
25.03.2013You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.